Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 9—September 2013
Dispatch

Benznidazole Treatment of Chagasic Encephalitis in Pregnant Woman with AIDS

Margarita BisioComments to Author , Jaime Altcheh, Jorge Lattner, Guillermo Moscatelli, Valeria Fink, Juan M. Burgos, Facundo García Bournissen, Alejandro G. Schijman, and Héctor Freilij
Author affiliations: Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina (M. Bisio, J. Altcheh, G. Moscatelli, F. García Bournissen, H. Freilij); Instituto de Investigaciones en Ingeniería Genética y Biología Molecular Dr Héctor N. Torres, Buenos Aires (M. Bisio, A.G. Schijman); Hospital Juan A. Fernández, Buenos Aires (J. Lattner, V. Fink); Facultad de Medicina de la Universidad de Buenos Aires, Buenos Aires (J.M. Burgos)

Main Article

Figure

Diagnosis, treatment, and prophylaxis monitoring of Trypanosoma cruzi infection in a pregnant woman and her daughter. The mother, who had chagasic encephalitis and AIDS, was treated with benznidazole (Bz). Po, positive; Ng, negative;  Nd, not determined; results of ELISA were considered positive when R was >1.2);  IHA, indirect hemagglutination assay (IHA was considered positive when titers were >16); kDNA-PCR, kinetoplast DNA-PCR; qPCR, quantitative PCR (dynamic range of detection: 1–105

Figure. . Diagnosis, treatment, and prophylaxis monitoring of Trypanosoma cruzi infection in a pregnant woman and her daughter. The mother, who had chagasic encephalitis and AIDS, was treated with benznidazole (Bz). Results of ELISA were considered positive when R was >1.2); results of IHA were considered positive when titers were >16. Po, positive; Ng, negative; Nd, not determined; IHA, indirect hemagglutination assay; kDNA-PCR, kinetoplast DNA-PCR; qPCR, quantitative PCR (dynamic range of detection: 1–105 parasite equivalents/mL, amplification efficiency 0.95, R2 = 0.996); par/mL, parasite equivalents/mL of blood; NQ, positive but not quantifiable; MRI, magnetic resonance imaging; gwk, gestational week; pd, postdelivery; tmt, Bz treatment (5 mg/kg/d); HAART, highly active antiretroviral therapy; ppx, Bz prophylaxis (5 mg/kg/3× per week).

Main Article

Page created: August 20, 2013
Page updated: August 20, 2013
Page reviewed: August 20, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external